Lucie Raskin: New FAERS Evidence Suggests Lower VTE Risk With Natural Estrogen COCs
Lucie Raskin, PhD student at University of Namur, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”New publication accepted in the American Journal of Obstetrics and Gynecology.
Our disproportionality analysis of the FAERS database provides new evidence suggesting that combined oral contraceptives containing natural estrogens may represent safer options regarding venous thromboembolic risk.
Pleased to share this work with Marie Didembourg, Jean-Michel Dogné, Mitchell Creinin, Médéa Locuet.
Special thanks to my promotors Jonathan Douxfils and Charlotte Beaudart.”
Title: Venous Thromboembolism with Combined Oral Contraceptives Based on Estrogen and Progestin Content: A disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database
Authors: Lucie Raskin, Marie Didembourg, Jean-Michel Dogné, Médéa Locquet, Mitchell D. Creinin, Charlotte Beaudart, Jonathan Douxfils
Read the Full Article on American Journal of Obstetrics and Gynecology
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral
-
Oct 21, 2026, 02:52Aymar Akilimali: Bleeding During Anticoagulation as a Potential Signal of Occult Cancer
-
Oct 21, 2026, 00:58Anees Ur Rahman: Completing a Two-Week Clinical Rotation at Haemophilia Treatment Centre Rawalpindi
-
Oct 21, 2026, 00:56Caitlyn Mooney: Pulmonary Embolism in Athletes, Recognition and Return to Sport
-
Oct 21, 2026, 00:54Hani Karrar: Pleased to Share Our Review on Emicizumab in Hemophilia A Management